BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 134661)

  • 1. On the significance of HL-A and LD antigens in myasthenia gravis.
    Pirskanen R
    Ann N Y Acad Sci; 1976; 274():451-60. PubMed ID: 134661
    [No Abstract]   [Full Text] [Related]  

  • 2. LD antigens associated with HL-A8 and myasthenia gravis.
    Kaakinen A; Pirskanen R; Tiilikainen A
    Tissue Antigens; 1975 Oct; 6(4):175-82. PubMed ID: 53901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic associations between myasthenia gravis and the HL-A system.
    Pirskanen R
    J Neurol Neurosurg Psychiatry; 1976 Jan; 39(1):23-33. PubMed ID: 1255208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HL-A8 and LD-8a in patients with myasthenia gravis.
    Möller E; Hammarström L; Smith E; Matell G
    Tissue Antigens; 1976 Jan; 7(1):39-44. PubMed ID: 56059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis: familial occurrence and HL-A types.
    Fritze D; Herrmann C; Walford RL
    Compr Ther; 1977 Apr; 3(4):19-25. PubMed ID: 852260
    [No Abstract]   [Full Text] [Related]  

  • 6. [The HLA system and the major histocompatibility complex in humans].
    Reali G
    Pathologica; 1975; 67(973-974):439-51. PubMed ID: 131932
    [No Abstract]   [Full Text] [Related]  

  • 7. Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report.
    Pirskanen R; Tiilikainen A; Hokkanen E
    Ann Clin Res; 1972 Oct; 4(5):304-6. PubMed ID: 4644453
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunoreactivity, HL-A antigen frequencies and clinical disease course of myasthenia gravis].
    Gross WL; Krüger J; Stewart U; Häckell U; Kunze K
    Verh Dtsch Ges Inn Med; 1975; 81():1178-81. PubMed ID: 1229431
    [No Abstract]   [Full Text] [Related]  

  • 9. HL-A antigens on hyperplastic and neoplastic thymic tissue.
    Naeim F; Stoddard A; Fritze D; Herrmann C; Zeller E; Walford RL
    Cancer Res; 1974 Mar; 34(3):654-6. PubMed ID: 4812266
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type.
    Simpson JA; Behan PO; Dick HM
    Ann N Y Acad Sci; 1976; 274():382-9. PubMed ID: 134659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biologic significance of HL-A antigen markers in myasthenia gravis.
    Fritze D; Herrmann C; Naeim F; Smith GS; Zeller E; Walford RL
    Ann N Y Acad Sci; 1976; 274():440-50. PubMed ID: 1066993
    [No Abstract]   [Full Text] [Related]  

  • 12. Myasthenia gravis, thrombocytopenia and HLA antigens.
    Remuzzi G; Livio M; Donati MB; De Gaetano G
    Ann Intern Med; 1977 Aug; 87(2):250-1. PubMed ID: 556565
    [No Abstract]   [Full Text] [Related]  

  • 13. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy.
    Mori T; Nomori H; Ikeda K; Kobayashi H; Iwatani K; Kobayashi T
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):364-8. PubMed ID: 17258565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The thymus in myasthenia gravis. Evidence for altered cell populations.
    Abdou NI; Lisak RP; Zweiman B; Abrahamsohn I; Penn AS
    N Engl J Med; 1974 Dec; 291(24):1271-5. PubMed ID: 4279335
    [No Abstract]   [Full Text] [Related]  

  • 15. Myasthenia gravis: studies on HL-A antigens and lymphocyte subpopulations in patients with myasthenia gravis.
    Hammarström L; Smith E; Möller E; Franksson C; Matell G; Von Reis G
    Clin Exp Immunol; 1975 Aug; 21(2):202-15. PubMed ID: 1081023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: HL-A antigens in myasthenia gravis.
    Fritze D; Herrmann C; Naeim F; Smith GS; Walford RL
    Lancet; 1974 Jul; 2(7871):43. PubMed ID: 4134425
    [No Abstract]   [Full Text] [Related]  

  • 17. HL-A antigens, autoantibody production, and associated diseases in thymoma patients, with and without myasthenia gravis.
    Oosterhuis HJ; Feltkamp TE; van Rossum AL; van den Berg-Loonen PM; Nijenhuis LE
    Ann N Y Acad Sci; 1976; 274():468-74. PubMed ID: 1085589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytes.
    Sheehy MJ; Sondel PM; Bach ML; Wank R; Bach FH
    Science; 1975 Jun; 188(4195):1308-10. PubMed ID: 124948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HL-A frequencies in patients with myasthenia gravis.
    Säfwenberg J; Lindblom JB; Osterman PO
    Tissue Antigens; 1973; 3(6):465-9. PubMed ID: 4775880
    [No Abstract]   [Full Text] [Related]  

  • 20. Myasthenia gravis, autoantibodies, and HL-A antigens.
    Feltkamp TE; van den Berg-Loonen PM; Nijenhuis LE; Engelfriet CP; van Rossum AL; van Loghem JJ; Oosterhuis HJ
    Br Med J; 1974 Jan; 1(5899):131-3. PubMed ID: 4544224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.